NEW YORK, July 19 - With $15 million in venture financing, Gene Logic said Thursday it has spun off a new company, Metrigenix, that will develop and commercialize its Flow-thru Chip microarray. 

Metrigenix.will market the Flow-thru Chip as a custom and pre-fabricated gene-based screening array to  pharmaceutical, biotechnology, and other life sciences companies. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.